Search Results

Using adult care visits to diagnose HIV infection in children, Burkina Faso.

• Authors : Tassembédo, Souleymane; Tiandiogo Traoré, Isidore; Traoré-Barro, Makoura

Subjects: HIV infection epidemiology; DIAGNOSIS of HIV infections; HIV preventionBURKINA Faso

• Source: Bulletin of the World Health Organization. Mar2024, Vol. 102 Issue 3, p187-195. 9p.

Record details

Costing of HIV services, Uganda and United Republic of Tanzania.

• Authors : McBain, Ryan K.; Jordan, Monica; Kapologwe, Ntuli A.

Subjects: MEDICAL economics; DIAGNOSIS of HIV infections; HIV preventionTANZANIA; UGANDA

• Source: Bulletin of the World Health Organization. Oct2023, Vol. 101 Issue 10, p626-636. 11p.

Record details

TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIRI DISOPROXILI FUMARAS).

Subjects: WORLD Health Organization; TENOFOVIR; ANTIRETROVIRAL agents

• Source: WHO Drug Information. 2023, Vol. 37 Issue 3, p657-669. 13p.

Record details

Prevention of mother-to-child transmission of hepatitis B virus in antenatal care and maternity services, Mozambique.

• Authors : Loarec, Anne; Nguyen, Aude; Molfino, Lucas

Subjects: HEPATITIS B prevention; DIAGNOSIS of syphilis; DIAGNOSIS of HIV infectionsSOUTH Africa

• Source: Bulletin of the World Health Organization. Jan2022, Vol. 100 Issue 1, p60-69. 10p.

Record details

Treatment-adjusted prevalence to assess HIV testing programmes.

• Authors : Tippett Barr, Beth A. (AUTHOR); Lowrance, David (AUTHOR); Johnson, Cheryl Case (AUTHOR)

Subjects: HIV infection epidemiology; HIV infections; WORLD Health OrganizationSUB-Saharan Africa

• Source: Bulletin of the World Health Organization. Dec2021, Vol. 99 Issue 12, p874-882. 9p. 2 Charts, 2 Graphs.

Record details

DOLUTEGRAVIR DISPERSIBLE TABLETS ( DOLUTEGRAVIRI COMPRESSI DISPERSIBILI).

Subjects: CHROMATOGRAPHS; ANTIRETROVIRAL agents; DRUG labeling

• Source: WHO Drug Information. 2021, Vol. 35 Issue 3, p684-690. 7p.

Record details

DOLUTEGRAVIR TABLETS.

Subjects: DOLUTEGRAVIR; DOSAGE forms of drugs; DRUG labeling

• Source: WHO Drug Information. 2020, Vol. 34 Issue 4, p857-861. 5p.

Record details

DOLUTEGRAVIR SODIUM.

Subjects: DOLUTEGRAVIR; ANALYTICAL chemistry; MOLECULAR structure

• Source: WHO Drug Information. 2020, Vol. 34 Issue 4, p846-856. 11p.

Record details

Integration of prevention and control measures for female genital schistosomiasis, HIV and cervical cancer.

• Authors : Engels, Dirk; Hotez, Peter J.; Ducker, Camilla

Subjects: HIV prevention; SCHISTOSOMIASIS prevention; TUMOR preventionSUB-Saharan Africa

• Source: Bulletin of the World Health Organization. Sep2020, Vol. 98 Issue 9, p615-624. 10p.

Record details

DOLUTEGRAVIR TABLETS DOLUTEGRAVIR COMPRESSI Draft proposal for inclusion in The International Pharmacopoeia (September 2019).

Subjects: BIOLOGICAL assay; DOSAGE forms of drugs; DRUG labeling

• Source: WHO Drug Information. 2019, Vol. 33 Issue 4, p738-744. 7p.

Record details